Гепатология
789 статей · 19 журналов
Журналы подкатегории (19)
- Annals of Hepatology · Elsevier (90)
- Journal of Hepatology · Elsevier (75)
- Journal of Hepato-Biliary-Pancreatic Sciences · Wiley (73)
- HPB · Elsevier (72)
- Gastroenterología y Hepatología · Elsevier (62)
- Gastroenterology · Elsevier (60)
- Journal of Clinical and Experimental Hepatology · Elsevier (59)
- Clinics in Liver Disease · Elsevier (48)
- Cellular and Molecular Gastroenterology and Hepatology · Elsevier (44)
- Journal of Liver Transplantation · Elsevier (44)
- Journal of Gastroenterology and Hepatology (Australia) · Wiley (41)
- The Lancet Gastroenterology & Hepatology · Elsevier (35)
- Liver International · Wiley (34)
- Portal Hypertension and Cirrhosis · Wiley (21)
- Liver Research · Elsevier (19)
- Journal of Viral Hepatitis · Wiley (12)
- Current Hepatology Reports · Springer Nature (0)
- Egyptian Liver Journal · Springer Nature (0)
- Hepatology International · Springer Nature (0)
- Lessons from the TRIPLET-HCC trial – Authors’ reply
- The implementation gap in aspirin chemoprevention for Lynch syndrome
- Combination therapy for MASH
- Validation of Rome V for irritable bowel syndrome
- Validation of Rome V for irritable bowel syndrome – Authors’ reply
- Tackling the global liver disease syndemic through primary care in the Asia-Pacific region
- Incidence of inflammatory bowel disease in Jakarta, Indonesia, 2021–24
- Research in Brief
- Long-term outcomes of top-down therapy versus a conventional step-up strategy in adults newly diagnosed with Crohn's disease: 5-year follow-up of the PROFILE trial
- On-demand transarterial chemoembolisation combined with atezolizumab and bevacizumab in patients with untreated hepatocellular carcinoma (TALENTACE): a multicentre, randomised, open-label, phase 3 trial
- ALG-055009 in non-cirrhotic adults with metabolic dysfunction-associated steatohepatitis (HERALD): a randomised, double-blind, placebo-controlled, phase 2a trial
- Germline multigene panel testing for colorectal cancer: a systematic review and meta-analysis
- Pathophysiology of irritable bowel syndrome
- The trajectory of inflammatory bowel disease in east and southeast Asia: transitioning from acceleration in incidence to compounding prevalence
- Global, regional, and national burden of gallbladder and biliary diseases in 204 countries and territories, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
- Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 48-week results from a multicentre, randomised, double-blind, phase 2b study
- Guinea-Bissau HepB birth-dose vaccine trial: still unethical
- Lessons from the European LiverScreen and Chinese LiverHealth projects
- Decompensation unmasks renal susceptibility in cirrhosis
- Aspirin after curative-intent treatment of colorectal cancer liver metastases (ASAC): a multicentre, phase 3, randomised, double-blind, placebo-controlled trial
- Prevalence of liver fibrosis and steatotic liver disease in community-dwelling adults in China (the CHESS-LiverHealth project): cross-sectional baseline data from a prospective cohort study
- Genetic variants and the risk of renal impairment in decompensated cirrhosis: a multi-ancestry genome-wide association study
- Short-course prophylaxis with the Toronto HCV protocol for recipients of non-liver solid organ transplants from donors with hepatitis C viraemia: a retrospective, matched cohort study
- Pain management in chronic pancreatitis: beyond opioids
- Strategies to develop therapeutic cancer vaccines for pancreatic cancer
- Kupffer cells: Orchestrators of liver physiology
- Evolving B-mode ultrasound-based techniques for assessing metabolic dysfunction-associated steatotic liver disease: Now and beyond
- Emerging role of proteomics in advancing diagnosis, prognosis, and treatment of liver cancer
- From bench to bedside: Molecular mechanisms, diagnostic tools, and therapeutic strategies in liver fibrosis
- Non-coding RNA networks in metabolic dysfunction-associated steatotic liver disease: Mechanisms and therapeutic perspectives